HBI Deals+Insights / Business Models and Strategy
Attendo's H1 results saw improvement as COVID's impact lessened. And while the effects of the pandemic clearly have had a negative impact on the listed Nordic care group, the market reacted positively. A share price which at the start of July was down over 35% on it's mid-February price rallied, and it is now just 10% down compared to its pre-COVID position.